Efficacy, Tolerability, and Dose-Dependent Effects of Opioid Analgesics for Low Back Pain: A Systematic Review and Meta-analysis
- PMID: 27213267
- DOI: 10.1001/jamainternmed.2016.1251
Efficacy, Tolerability, and Dose-Dependent Effects of Opioid Analgesics for Low Back Pain: A Systematic Review and Meta-analysis
Abstract
Importance: Opioid analgesics are commonly used for low back pain, however, to our knowledge there has been no systematic evaluation of the effect of opioid dose and use of enrichment study design on estimates of treatment effect.
Objective: To evaluate efficacy and tolerability of opioids in the management of back pain; and investigate the effect of opioid dose and use of an enrichment study design on treatment effect.
Data sources: Medline, EMBASE, CENTRAL, CINAHL, and PsycINFO (inception to September 2015) with citation tracking from eligible randomized clinical trials (RCTs).
Study selection: Placebo-controlled RCTs in any language.
Data extraction and synthesis: Two authors independently extracted data and assessed risk of bias. Data were pooled using a random effects model with strength of evidence assessed using the grading of recommendations assessment, development, and evaluation (GRADE).
Main outcomes and measures: The primary outcome measure was pain. Pain and disability outcomes were converted to a common 0 to 100 scale, with effects greater than 20 points considered clinically important.
Results: Of 20 included RCTs of opioid analgesics (with a total of 7925 participants), 13 trials (3419 participants) evaluated short-term effects on chronic low back pain, and no placebo-controlled trials enrolled patients with acute low back pain. In half of these 13 trials, at least 50% of participants withdrew owing to adverse events or lack of efficacy. There was moderate-quality evidence that opioid analgesics reduce pain in the short term; mean difference (MD), -10.1 (95% CI, -12.8 to -7.4). Meta-regression revealed a 12.0 point greater pain relief for every 1 log unit increase in morphine equivalent dose (P = .046). Clinically important pain relief was not observed within the dose range evaluated (40.0-240.0-mg morphine equivalents per day). There was no significant effect of enrichment study design.
Conclusions and relevance: For people with chronic low back pain who tolerate the medicine, opioid analgesics provide modest short-term pain relief but the effect is not likely to be clinically important within guideline recommended doses. Evidence on long-term efficacy is lacking. The efficacy of opioid analgesics in acute low back pain is unknown.
Comment in
-
Avoiding Opioid Analgesics for Treatment of Chronic Low Back Pain.JAMA. 2016 Jun 14;315(22):2459-60. doi: 10.1001/jama.2016.6753. JAMA. 2016. PMID: 27299620 No abstract available.
Similar articles
-
Efficacy and tolerability of muscle relaxants for low back pain: Systematic review and meta-analysis.Eur J Pain. 2017 Feb;21(2):228-237. doi: 10.1002/ejp.907. Epub 2016 Jun 22. Eur J Pain. 2017. PMID: 27329976 Review.
-
[Opioids in chronic low back pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration].Schmerz. 2015 Feb;29(1):60-72. doi: 10.1007/s00482-014-1449-8. Schmerz. 2015. PMID: 25503883 Review. German.
-
Efficacy, safety, and dose-dependence of the analgesic effects of opioid therapy for people with osteoarthritis: systematic review and meta-analysis.Med J Aust. 2022 Apr 4;216(6):305-311. doi: 10.5694/mja2.51392. Epub 2022 Feb 9. Med J Aust. 2022. PMID: 35137418 Review.
-
Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.Pain Physician. 2017 Feb;20(2S):S3-S92. Pain Physician. 2017. PMID: 28226332
-
Opioids for Chronic Noncancer Pain: A Systematic Review and Meta-analysis.JAMA. 2018 Dec 18;320(23):2448-2460. doi: 10.1001/jama.2018.18472. JAMA. 2018. PMID: 30561481 Free PMC article.
Cited by
-
The Analgesic and Side Effects of Tramadol Hydrochloride Immediate-Release and Extended-Release Tablets in Patients With Chronic Low Back Pain.Cureus. 2024 Oct 22;16(10):e72124. doi: 10.7759/cureus.72124. eCollection 2024 Oct. Cureus. 2024. PMID: 39575060 Free PMC article.
-
Research hotspots and frontiers in non-specific low back pain: a bibliometric analysis.Front Neurol. 2024 Oct 30;15:1464048. doi: 10.3389/fneur.2024.1464048. eCollection 2024. Front Neurol. 2024. PMID: 39539665 Free PMC article.
-
Exceeding the guideline-recommended maximum daily dose of opioids for long-term treatment of non-cancer pain in Germany - a large retrospective observational study.BMC Public Health. 2024 Sep 27;24(1):2580. doi: 10.1186/s12889-024-20141-4. BMC Public Health. 2024. PMID: 39334000 Free PMC article.
-
Opioid-related mortality after occupational injury in Washington State: accounting for preinjury opioid use.Occup Environ Med. 2024 Oct 23;81(10):515-521. doi: 10.1136/oemed-2024-109606. Occup Environ Med. 2024. PMID: 39327042
-
M2 Macrophage-Derived Small Extracellular Vesicles Ameliorate Pyroptosis and Intervertebral Disc Degeneration.Biomater Res. 2024 Jul 1;28:0047. doi: 10.34133/bmr.0047. eCollection 2024. Biomater Res. 2024. PMID: 38952714 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
